Operose Advisors’s Amdocs DOX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$8.16K Hold
125
﹤0.01% 424
2025
Q4
$10.1K Hold
125
﹤0.01% 378
2025
Q3
$10.3K Hold
125
﹤0.01% 357
2025
Q2
$11.4K Hold
125
﹤0.01% 325
2025
Q1
$11.4K Hold
125
﹤0.01% 310
2024
Q4
$10.6K Sell
125
-185
-60% -$16.2K ﹤0.01% 303
2024
Q3
$27.1K Hold
310
0.01% 361
2024
Q2
$24.5K Hold
310
0.01% 329
2024
Q1
$28K Hold
310
0.01% 330
2023
Q4
$27.2K Hold
310
0.01% 308
2023
Q3
$26.2K Buy
310
+185
+148% +$16.7K 0.01% 424
2023
Q2
$12.4K Hold
125
0.01% 265
2023
Q1
$12K Hold
125
0.01% 259
2022
Q4
$11.4K Buy
+125
New +$10.6K 0.01% 268

Other funds holding DOX

Operose Advisors's DOX Position: Q1 2026 in Review

Operose Advisors held its Amdocs (DOX) position steady in Q1 2026 at 125 shares worth $8.16K. The position accounts for ﹤0.01% of the portfolio, ranked #424.

Operose Advisors first reported a position in DOX in Q4 2022 and has held it in 14 quarters since. The position peaked at $28K in Q1 2024. 473 funds tracked by Wall St. Rank hold DOX as of Q1 2026.

  • Operose Advisors held 125 shares of Amdocs worth $8.16K as of Q1 2026.
  • Operose Advisors left its Amdocs share count unchanged in Q1 2026.
  • Amdocs made up ﹤0.01% of Operose Advisors's portfolio in Q1 2026, its #424 holding.
  • Operose Advisors first reported a position in Amdocs in Q4 2022 and has held it in 14 quarters since.
  • Operose Advisors's Amdocs position peaked at $28K in Q1 2024.
  • 473 funds tracked by Wall St. Rank held Amdocs as of Q1 2026.

Based on Operose Advisors's 13F filing for Q1 2026, filed 12 May 2026.